Merck Strikes Deal to Produce COVID-19 Vaccine of Rival Johnson & Johnson

HeadlineMar 02, 2021

About one in five U.S. residents over the age of 18 have been vaccinated. And the pace of inoculations is set to pick up, with the first shots of Johnson & Johnson’s single-dose COVID-19 vaccine due to be administered today. This comes as the Biden administration is announcing it has secured a deal to have the pharmaceutical giant Merck produce shots of Johnson & Johnson’s vaccine in a move that could sharply boost supply. 

The original content of this program is licensed under a Creative Commons Attribution-Noncommercial-No Derivative Works 3.0 United States License. Please attribute legal copies of this work to Some of the work(s) that this program incorporates, however, may be separately licensed. For further information or additional permissions, contact us.

Non-commercial news needs your support

We rely on contributions from our viewers and listeners to do our work.
Please do your part today.
Make a donation